Effect of interleukin 12 (IL-12) on embryonic development and yolk sac vascularisation

Insights

Interleukin-12 (IL-12) exposure during in vitro embryo culture significantly hinders yolk sac vascularization and embryonic development. This study demonstrates IL-12

Area of Science:

  • Developmental Biology
  • Embryology
  • Vascular Biology

Background:

  • Angiogenic diseases are increasing, characterized by abnormal blood vessel formation.
  • Embryonic vascular development is crucial and occurs early in gestation.
  • In vitro embryo culture models, like rat embryos (9.5-11.5 days), are valuable for studying vascularization.

Purpose of the Study:

  • To investigate the antiangiogenic effects of Interleukin-12 (IL-12) on yolk sac vascularization.
  • To assess the impact of IL-12 on early embryonic development in vitro.

Main Methods:

  • Rat embryos (9.5-11.5 days gestation) were cultured in vitro for 48 hours.
  • Different concentrations of IL-12 (50, 100, 200 ng/ml) were added to the culture serum.
  • Morphological assessments were performed to evaluate developmental parameters.

Main Results:

  • IL-12 exposure significantly retarded embryonic development, including yolk sac diameter, crown rump length, and somite number.
  • Poor development of yolk sac vascularization and the heart was observed in IL-12 treated groups.
  • Developmental retardations were statistically significant compared to controls.

Conclusions:

  • Interleukin-12 exhibits significant antiangiogenic properties.
  • IL-12 can impede embryonic development, likely through its antiangiogenic mechanism.
  • This study highlights the potential role of IL-12 in regulating vascularization during embryogenesis.
Abstract